泰凌醫藥：2020中期報告.pdf

1、Interim Report 2020 中期報告 INTERIM REPORT中 期 報 告(Incorporated in the Cayman Islands with limited liability)(於開曼群島註冊成立之有限公司)CONTENTS 目 錄Board of Directors and Board Committees董事會及董事委員會Corporate Information公司資料Financial Highlights財務摘要Management Discussion and Analysis管理層討論及分析Other Information其他資料Condens

2、ed Consolidated Income Statement簡明綜合收益表Condensed Consolidated Statement of Comprehensive Income簡明綜合全面收益表Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表Condensed Consolidated Statement of Cash Flow簡明綜合現金流量表Notes to the Cond

3、ensed Consolidated Interim Financial Statements簡明綜合中期財務報表附註2467243638394142432China NT Pharma Group Company Limited Interim Report 2020Board of Directors and Board Committees董事會及董事委員會BOARD OF DIRECTORS董事會Executive DirectorsMr.NG Tit(Chairman and Chief Executive Officer)執行董事吳鐵先生（主席兼行政總裁）Ms.CHIN Yu錢余女

4、士Mr.WU Weizhong吳為忠先生Non-executive DirectorDr.QIAN Wei非執行董事錢唯博士Independent Non-executive DirectorsMr.YU Tze Shan Hailson獨立非執行董事余梓山先生Dr.ZHAO Yubiao 趙玉彪博士Mr.PAN Fei(appointed on 20 March 2020)潘飛先生（於2020年3月20日獲委任）Dr.YAN Hong(resigned on 20 March 2020)嚴弘博士（於2020年3月20日辭任）3中國泰凌醫藥集團有限公司 中期報告 2020Board of Di

5、rectors and Board Committees(Continued)董事會及董事委員會（續）BOARD COMMITTEES董事委員會Audit CommitteeMr.PAN Fei(Chairman)(appointed on 20 March 2020)審核委員會潘飛先生（主席）（於2020年3月20日獲委任）Mr.YU Tze Shan Hailson余梓山先生Dr.ZHAO Yubiao(appointed on 20 March 2020)趙玉彪博士（於2020年3月20日獲委任）Dr.YAN Hong(resigned on 20 March 2020)嚴弘博士（於20

6、20年3月20日辭任）Remuneration CommitteeMr.YU Tze Shan Hailson(Chairman)薪酬委員會余梓山先生（主席）Mr.NG Tit吳鐵先生Dr.ZHAO Yubiao趙玉彪博士Nomination CommitteeMr.NG Tit(Chairman)提名委員會吳鐵先生（主席）Mr.YU Tze Shan Hailson余梓山先生Dr.ZHAO Yubiao趙玉彪博士China NT Pharma Group Company Limited Interim Report 20204Corporate Information公司資料COMPANY